These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
319 related articles for article (PubMed ID: 33409797)
1. An MRI-based radiomics signature as a pretreatment noninvasive predictor of overall survival and chemotherapeutic benefits in lower-grade gliomas. Wang J; Zheng X; Zhang J; Xue H; Wang L; Jing R; Chen S; Che F; Heng X; Li G; Xue F Eur Radiol; 2021 Apr; 31(4):1785-1794. PubMed ID: 33409797 [TBL] [Abstract][Full Text] [Related]
2. Radiomics Nomogram Building From Multiparametric MRI to Predict Grade in Patients With Glioma: A Cohort Study. Wang Q; Li Q; Mi R; Ye H; Zhang H; Chen B; Li Y; Huang G; Xia J J Magn Reson Imaging; 2019 Mar; 49(3):825-833. PubMed ID: 30260592 [TBL] [Abstract][Full Text] [Related]
3. MRI-based radiomics signature and clinical factor for predicting H3K27M mutation in pediatric high-grade gliomas located in the midline of the brain. Wu C; Zheng H; Li J; Zhang Y; Duan S; Li Y; Wang D Eur Radiol; 2022 Mar; 32(3):1813-1822. PubMed ID: 34655310 [TBL] [Abstract][Full Text] [Related]
4. Radiomics Features of Multiparametric MRI as Novel Prognostic Factors in Advanced Nasopharyngeal Carcinoma. Zhang B; Tian J; Dong D; Gu D; Dong Y; Zhang L; Lian Z; Liu J; Luo X; Pei S; Mo X; Huang W; Ouyang F; Guo B; Liang L; Chen W; Liang C; Zhang S Clin Cancer Res; 2017 Aug; 23(15):4259-4269. PubMed ID: 28280088 [No Abstract] [Full Text] [Related]
5. Development and external validation of an MRI-based radiomics nomogram for pretreatment prediction for early relapse in osteosarcoma: A retrospective multicenter study. Chen H; Liu J; Cheng Z; Lu X; Wang X; Lu M; Li S; Xiang Z; Zhou Q; Liu Z; Zhao Y Eur J Radiol; 2020 Aug; 129():109066. PubMed ID: 32502729 [TBL] [Abstract][Full Text] [Related]
6. MRI-based radiomics nomogram may predict the response to induction chemotherapy and survival in locally advanced nasopharyngeal carcinoma. Zhao L; Gong J; Xi Y; Xu M; Li C; Kang X; Yin Y; Qin W; Yin H; Shi M Eur Radiol; 2020 Jan; 30(1):537-546. PubMed ID: 31372781 [TBL] [Abstract][Full Text] [Related]
7. A radiomics feature-based nomogram to predict telomerase reverse transcriptase promoter mutation status and the prognosis of lower-grade gliomas. Lu J; Li X; Li H Clin Radiol; 2022 Aug; 77(8):e560-e567. PubMed ID: 35595562 [TBL] [Abstract][Full Text] [Related]
8. A radiomics nomogram may improve the prediction of IDH genotype for astrocytoma before surgery. Tan Y; Zhang ST; Wei JW; Dong D; Wang XC; Yang GQ; Tian J; Zhang H Eur Radiol; 2019 Jul; 29(7):3325-3337. PubMed ID: 30972543 [TBL] [Abstract][Full Text] [Related]
9. A radiomic signature as a non-invasive predictor of progression-free survival in patients with lower-grade gliomas. Liu X; Li Y; Qian Z; Sun Z; Xu K; Wang K; Liu S; Fan X; Li S; Zhang Z; Jiang T; Wang Y Neuroimage Clin; 2018; 20():1070-1077. PubMed ID: 30366279 [TBL] [Abstract][Full Text] [Related]
10. Thin-Slice Magnetic Resonance Imaging-Based Radiomics Signature Predicts Chromosomal 1p/19q Co-deletion Status in Grade II and III Gliomas. Kong Z; Jiang C; Zhang Y; Liu S; Liu D; Liu Z; Chen W; Liu P; Yang T; Lyu Y; Zhao D; You H; Wang Y; Ma W; Feng F Front Neurol; 2020; 11():551771. PubMed ID: 33192984 [No Abstract] [Full Text] [Related]
11. A nomogram strategy for identifying the subclassification of IDH mutation and ATRX expression loss in lower-grade gliomas. Wu S; Zhang X; Rui W; Sheng Y; Yu Y; Zhang Y; Yao Z; Qiu T; Ren Y Eur Radiol; 2022 May; 32(5):3187-3198. PubMed ID: 35133485 [TBL] [Abstract][Full Text] [Related]
12. Development of a nomograph integrating radiomics and deep features based on MRI to predict the prognosis of high grade Gliomas. Wang Y; Shao Q; Luo S; Fu R Math Biosci Eng; 2021 Sep; 18(6):8084-8095. PubMed ID: 34814290 [TBL] [Abstract][Full Text] [Related]
13. Radiomics analysis allows for precise prediction of epilepsy in patients with low-grade gliomas. Liu Z; Wang Y; Liu X; Du Y; Tang Z; Wang K; Wei J; Dong D; Zang Y; Dai J; Jiang T; Tian J Neuroimage Clin; 2018; 19():271-278. PubMed ID: 30035021 [TBL] [Abstract][Full Text] [Related]
14. A radiomics nomogram for the prediction of overall survival in patients with hepatocellular carcinoma after hepatectomy. Liu Q; Li J; Liu F; Yang W; Ding J; Chen W; Wei Y; Li B; Zheng L Cancer Imaging; 2020 Nov; 20(1):82. PubMed ID: 33198809 [TBL] [Abstract][Full Text] [Related]
15. Preoperative prediction of pelvic lymph nodes metastasis in early-stage cervical cancer using radiomics nomogram developed based on T2-weighted MRI and diffusion-weighted imaging. Wang T; Gao T; Yang J; Yan X; Wang Y; Zhou X; Tian J; Huang L; Zhang M Eur J Radiol; 2019 May; 114():128-135. PubMed ID: 31005162 [TBL] [Abstract][Full Text] [Related]
16. Noninvasive prediction of IDH mutation status in gliomas using preoperative multiparametric MRI radiomics nomogram: A mutlicenter study. Lu J; Xu W; Chen X; Wang T; Li H Magn Reson Imaging; 2023 Dec; 104():72-79. PubMed ID: 37778708 [TBL] [Abstract][Full Text] [Related]
17. Improving survival prediction of high-grade glioma via machine learning techniques based on MRI radiomic, genetic and clinical risk factors. Tan Y; Mu W; Wang XC; Yang GQ; Gillies RJ; Zhang H Eur J Radiol; 2019 Nov; 120():108609. PubMed ID: 31606714 [TBL] [Abstract][Full Text] [Related]
18. Prognostic value of multiparametric MRI-based radiomics model: Potential role for chemotherapeutic benefits in locally advanced rectal cancer. Cui Y; Yang W; Ren J; Li D; Du X; Zhang J; Yang X Radiother Oncol; 2021 Jan; 154():161-169. PubMed ID: 32976874 [TBL] [Abstract][Full Text] [Related]
19. Radiomics analysis of multiparametric MRI for prediction of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Cui Y; Yang X; Shi Z; Yang Z; Du X; Zhao Z; Cheng X Eur Radiol; 2019 Mar; 29(3):1211-1220. PubMed ID: 30128616 [TBL] [Abstract][Full Text] [Related]
20. Radiomics signature of brain metastasis: prediction of EGFR mutation status. Wang G; Wang B; Wang Z; Li W; Xiu J; Liu Z; Han M Eur Radiol; 2021 Jul; 31(7):4538-4547. PubMed ID: 33439315 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]